Role of Medical Imaging in Cancers

doi:10.3390/books978-3-0365-0207-6

dc.contributor.editor	Fanti, Stefano
dc.contributor.editor	Evangelista, Laura
dc.date.accessioned	2021-05-01T15:10:42Z
dc.date.available	2021-05-01T15:10:42Z
dc.date.issued	2021
dc.identifier	ONIX_20210501_9783036502069_209
dc.identifier.uri	https://directory.doabooks.org/handle/20.500.12854/68463
dc.description.abstract	The issue of Cancers Journal entitled “Role of Medical Imaging in Cancers” presents a detailed summary of evidences about molecular imaging, including the role of computed tomography (CT), magnetic resonance imaging (MRI), single photon emission tomography (SPET) and positron emission tomography (PET) or PET/CT or PET/MR imaging in many type of tumors (i.e. sarcoma, prostate, breast and others), motivating the role of these imaging modalities in different setting of disease and showing the recent developments, in terms of radiopharmaceuticals, software and artificial intelligence in this field. The collection of articles is very useful for many specialists, because it has been conceived for a multidisciplinary point of view, in order to drive to a personalized medicine.
dc.language	English
dc.subject.classification	thema EDItEUR::M Medicine and Nursing	en_US
dc.subject.other	positron emission tomography
dc.subject.other	head and neck neoplasms
dc.subject.other	neovascularization
dc.subject.other	pathologic
dc.subject.other	PET/CT
dc.subject.other	urothelial carcinoma
dc.subject.other	bladder cancer
dc.subject.other	upper tract urothelial carcinoma
dc.subject.other	survival
dc.subject.other	PET
dc.subject.other	PSMA
dc.subject.other	prostate
dc.subject.other	DCFPyL
dc.subject.other	DCFBC
dc.subject.other	PSMA-1007
dc.subject.other	ovarian cancer
dc.subject.other	relapse
dc.subject.other	SUVmax
dc.subject.other	targeted therapy
dc.subject.other	prognosis
dc.subject.other	soft tissue sarcoma (STS)
dc.subject.other	pazopanib
dc.subject.other	dynamic 18F-FDG PET/CT
dc.subject.other	SUV
dc.subject.other	two-tissue compartment model
dc.subject.other	magnetic resonance imaging
dc.subject.other	machine learning
dc.subject.other	diffusion
dc.subject.other	perfusion
dc.subject.other	texture analysis
dc.subject.other	squamous cell carcinoma of the head and neck
dc.subject.other	diffusion-weighted imaging
dc.subject.other	malignant pleural mesothelioma
dc.subject.other	pleural dissemination
dc.subject.other	empyema
dc.subject.other	pleural effusion
dc.subject.other	mCRPC
dc.subject.other	SPECT/CT
dc.subject.other	Computer-assisted diagnosis
dc.subject.other	XOFIGO
dc.subject.other	Therapy response assessment
dc.subject.other	circulating miRNAs
dc.subject.other	breast cancer
dc.subject.other	imaging parameters
dc.subject.other	PET/MRI
dc.subject.other	biomarkers
dc.subject.other	triple negative breast cancer
dc.subject.other	VCAM-1
dc.subject.other	SPECT imaging
dc.subject.other	sdAbs
dc.subject.other	Hounsfield unit
dc.subject.other	computed tomography
dc.subject.other	adipose tissue
dc.subject.other	precision oncology
dc.subject.other	FDG-PET/CT
dc.subject.other	PERCIST
dc.subject.other	metastatic breast cancer
dc.subject.other	prostate cancer
dc.subject.other	18F-FACBC
dc.subject.other	recurrence
dc.subject.other	meta-analysis
dc.subject.other	review
dc.subject.other	meningioma
dc.subject.other	somatostatin receptor
dc.subject.other	neuroimaging
dc.subject.other	radionuclide therapy
dc.subject.other	breast
dc.subject.other	imaging
dc.subject.other	marker
dc.subject.other	radiomics
dc.subject.other	Yin Yang 1
dc.subject.other	PDAC
dc.subject.other	Mesothelin
dc.subject.other	noninvasive imaging
dc.subject.other	receptor status
dc.subject.other	molecular imaging
dc.subject.other	nuclear medicine
dc.subject.other	guidelines
dc.subject.other	overutilization
dc.subject.other	epistemology
dc.subject.other	consensus
dc.subject.other	mantle cell lymphoma
dc.subject.other	18F-FDG PET/CT
dc.subject.other	Deauville criteria
dc.subject.other	Radium-223
dc.subject.other	FDG
dc.subject.other	castrate resistant prostate cancer
dc.subject.other	programmed cell death 1 receptor
dc.subject.other	diagnostic imaging
dc.subject.other	CTLA-4 Antigen
dc.subject.other	Immunotherapy
dc.subject.other	Adoptive
dc.subject.other	radioactive tracers
dc.subject.other	radionuclide imaging
dc.subject.other	CD8-Positive T-Lymphocytes
dc.subject.other	PI-RADS
dc.subject.other	diffusion kurtosis imaging
dc.subject.other	dynamic contrast-enhanced magnetic resonance imaging
dc.subject.other	68Gallium-PSMA PET/CT
dc.subject.other	prostate-specific-antigen
dc.subject.other	PSA kinetics thresholds
dc.subject.other	biochemical recurrence
dc.subject.other	optimal cutoff level
dc.subject.other	non-small-cell lung cancer
dc.subject.other	circulating tumor cells
dc.subject.other	immunotherapy
dc.subject.other	response to treatment
dc.subject.other	head and neck cancer
dc.subject.other	HPV
dc.subject.other	EBV
dc.subject.other	p16
dc.subject.other	Molecular imaging
dc.subject.other	miRNA expression
dc.subject.other	radiogenomics
dc.subject.other	radiomic
dc.subject.other	diagnosis
dc.subject.other	biomarker
dc.subject.other	glioblastoma
dc.subject.other	radiation therapy
dc.subject.other	MRI
dc.subject.other	diffusion tensor imaging
dc.subject.other	Hodgkin lymphoma
dc.subject.other	diffuse large B-cell lymphoma
dc.subject.other	staging
dc.subject.other	response assessment
dc.subject.other	locally advanced cervical cancer
dc.subject.other	concurrent chemoradiotherapy
dc.subject.other	treatment response
dc.subject.other	follow up
dc.subject.other	cystic tumor
dc.subject.other	International Consensus Guidelines
dc.subject.other	intraductal papillary mucinous neoplasms
dc.subject.other	pancreatic neoplasms
dc.subject.other	PD-1
dc.subject.other	PD-L1
dc.subject.other	response to therapy
dc.subject.other	NSCLC
dc.subject.other	positron-emission tomography
dc.subject.other	single-photon emission computed tomography
dc.subject.other	immune checkpoint inhibitors
dc.subject.other	gold nanoparticle
dc.subject.other	heat shock protein 70
dc.subject.other	spectral-CT
dc.subject.other	n/a
dc.title	Role of Medical Imaging in Cancers
dc.type	book
oapen.identifier.doi	10.3390/books978-3-0365-0207-6
oapen.relation.isPublishedBy	46cabcaa-dd94-4bfe-87b4-55023c1b36d0
oapen.relation.isbn	9783036502069
oapen.relation.isbn	9783036502076
oapen.pages	228
oapen.place.publication	Basel, Switzerland

Files in this item

Files	Size	Format	View
There are no files associated with this item.

This item appears in the following Collection(s)

Imported or submitted locally

Show simple item record

Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0/